LBA74 Zongertinib as first-line treatment in patients with advanced HER2-mutant NSCLC: Beamion LUNG 1

作者：S. Popat, Norio Yamamoto, N. Girard, Yi‐Long Wu, G. Ruiter, E.F. Smit, K. Yoh, Hai‐Yan Tu, J. Zugazagoitia, J. Sabari, Thomas Wehler, E. Nadal, Jiřı́ Stöhr, B. Sadrolhefazi, H. Luess, J. Heymach · 发表于：Annals of Oncology · 年份：2025 · DOI：10.1016/j.annonc.2025.09.088 · 被引用次数：6 · 研究领域：Lung Cancer Treatments and Mutations、Chronic Myeloid Leukemia Treatments、Melanoma and MAPK Pathways